S O'brien - JoVE Visualize

Showing results (721-730 of 1,023) with videos related to

Pageof 103

Sort By:

Journal of Glaucoma|September 2, 2025

Open-Angle Glaucoma Treatment Preferences of US Glaucoma SpecialistsJocelyn Liu, Iris M Kim, Evan M Chen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemiaM J Keating, H Kantarjian, S O'Brien, et al.

Leukemia|October 27, 1997

Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaN Vey, H Kantarjian, H Tran, et al.

Accident; Analysis and Prevention|November 12, 2017

Prediction of drowsiness events in night shift workers during morning drivingYulan Liang, William J Horrey, Mark E Howard, et al.

Leukemia Research|December 13, 2006

Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML)F Ravandi, I Jilani, E Estey, et al.

Cancer|January 1, 1990

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemiaH M Kantarjian, R L Walters, M J Keating, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998

Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)M Beran, X Cao, Z Estrov, et al.

Blood|November 1, 1995

Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.

The New England Journal of Medicine|September 9, 1993

Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.

Pageof 103

Showing results (721-730 of 1,023) with videos related to

Sort By:

Pageof 103

Journal of Glaucoma|September 2, 2025

Open-Angle Glaucoma Treatment Preferences of US Glaucoma SpecialistsJocelyn Liu, Iris M Kim, Evan M Chen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemiaM J Keating, H Kantarjian, S O'Brien, et al.

Leukemia|October 27, 1997

Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaN Vey, H Kantarjian, H Tran, et al.

Accident; Analysis and Prevention|November 12, 2017

Prediction of drowsiness events in night shift workers during morning drivingYulan Liang, William J Horrey, Mark E Howard, et al.

Leukemia Research|December 13, 2006

Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML)F Ravandi, I Jilani, E Estey, et al.

Cancer|January 1, 1990

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemiaH M Kantarjian, R L Walters, M J Keating, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998

Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)M Beran, X Cao, Z Estrov, et al.

Blood|November 1, 1995

Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.

The New England Journal of Medicine|September 9, 1993

Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.

Pageof 103